Sapu003 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16 results for “Sapu003”

Trials

Sapu003 in Advanced mTOR-sensitive Solid Tumors

27 participants · First posted Jan 27, 2026

A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions

11 participants · First posted Nov 27, 2020

Active, not recruiting

A Study of SPY003-207 in Healthy Volunteers

59 participants · First posted Mar 13, 2025

Drugs

SPN003

Anagrelide-SAR003

AcNK-Sup003

News

Sapu Nano's Injectable Everolimus Formulation Sapu003 Receives Approval for Phase 1 Breast Cancer Trial

Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy

Oncotelic Therapeutics Expands Global Patent Protection for OT-101 TGF-β Antisense Therapy Across CNS and Neurology Applications

Page 1 of 2